SEC Form SC 13G/A filed by Zepp Health Corporation (Amendment)

2/8/24 5:22:46 PM ET

Computer Manufacturing

Technology

Get the next $ZEPP alert in real time by email

SC 13G/A 1 HUAMI.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Zepp Health Corp ------------------------------------------------------------------------------- (Name of Issuer) American depositary shares (each representing four Class A ordinary shares, par value US$0.0001 per share) ------------------------------------------------------------------------------- (Title of Class of Securities) 44331K103 -------------------------------------------- (CUSIP Number)** December 29, 2023 ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [] Rule 13d-1(c) [] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). **CUSIP represents American Depositary Shares each representing four Class A ordinary shares. Page 1 of 8 ----------------------- CUSIP No. 44331K103 13G ----------------------- ------------------------------------------------------------------------------ 1. Name of Reporting Person I.R.S. Identification No. of above Person Goldman Sachs Asset Management, L.P. ------------------------------------------------------------------------------ 2. Check the Appropriate Box if a Member of a Group (a) [_] (b) [_] ------------------------------------------------------------------------------ 3. SEC Use Only ------------------------------------------------------------------------------ 4. Citizenship or Place of Organization Delaware ------------------------------------------------------------------------------ 5. Sole Voting Power Number of 0 Shares ---------------------------------------------------------- 6. Shared Voting Power Beneficially 0 Owned by ---------------------------------------------------------- Each 7. Sole Dispositive Power Reporting 0 Person ---------------------------------------------------------- 8. Shared Dispositive Power With: 0 ------------------------------------------------------------------------------ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 0 ------------------------------------------------------------------------------ 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares [_] ------------------------------------------------------------------------------ 11. Percent of Class Represented by Amount in Row (9) 0.0 % ------------------------------------------------------------------------------ 12. Type of Reporting Person IA ------------------------------------------------------------------------------ Page 2 of 8 Item 1(a). Name of Issuer: Zepp Health Corp Item 1(b). Address of Issuer's Principal Executive Offices: Building B2, Zhong'an Chuanggu Technology Park No. 900 Wangjiang West Road Hefei, 230088 People's Republic of China Item 2(a). Name of Persons Filing: GOLDMAN SACHS ASSET MANAGEMENT Item 2(b). Address of Principal Business Office or, if none, Residence: Goldman Sachs Asset Management 200 West Street New York, NY 10282 Item 2(c). Citizenship: GOLDMAN SACHS ASSET MANAGEMENT, L.P. - Delaware Item 2(d). Title of Class of Securities: American depositary shares (each representing four Class A ordinary shares, par value US$0.0001 per share) Item 2(e). CUSIP Number: 44331K103 Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: (a).[_] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b).[_] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c).[_] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d).[_] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e).[X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); Goldman Sachs Asset Management, L.P. (f).[_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g).[_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h).[_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i).[_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j).[_] A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k).[_] A group, in accordance with Rule 13d-1(b)(1)(ii) (A) through (K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: Page 3 of 8 Item 4. Ownership.* (a). Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s). (b). Percent of Class: See the response(s)to Item 11 on the attached cover page(s). (c). Number of shares as to which such person has: (i). Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s). (ii). Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s). (iii). Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s). (iv). Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s). Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Clients of the Reporting Person(s) have or may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities held in their accounts. Clients known to have such right or power with respect to more than 5% of the class of securities to which this report relates are: NONE Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Section 240.14a-11. -------------------------- *In accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned by certain operating units (collectively, the "Goldman Sachs Reporting Units") of The Goldman Sachs Group, Inc. and its subsidiaries and affiliates (collectively, "GSG"). This filing does not reflect securities, if any, beneficially owned by any operating units of GSG whose ownership of securities is disaggregated from that of the Goldman Sachs Reporting Units in accordance with the Release. The Goldman Sachs Reporting Units disclaim beneficial ownership of the securities beneficially owned by (i) any client accounts with respect to which the Goldman Sachs Reporting Units or their employees have voting or investment discretion or both, or with respect to which there are limits on their voting or investment authority or both and (ii) certain investment entities of which the Goldman Sachs Reporting Units act as the general partner, managing general partner or other manager, to the extent interests in such entities are held by persons other than the Goldman Sachs Reporting Units. Page 4 of 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 04, 2024, GOLDMAN SACHS ASSET MANAGEMENT, L.P. By:/s/ Kateryna Osmachko ---------------------------------------- Name: Kateryna Osmachko Title: Attorney-in-fact Page 5 of 8 INDEX TO EXHIBITS Exhibit No. Exhibit ----------- ------- 99.1 Joint Filing Agreement 99.2 Power of Attorney, relating to GOLDMAN SACHS ASSET MANAGEMENT, L.P. Page 6 of 8 EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the American depositary shares (each representing four Class A ordinary shares, par value US$0.0001 per share), of Zepp Health Corp and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: February 04, 2024, GOLDMAN SACHS ASSET MANAGEMENT, L.P. By:/s/ Kateryna Osmachko ---------------------------------------- Name: Kateryna Osmachko Title: Attorney-in-fact Page 7 of 8 EXHIBIT (99.2) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that GOLDMAN SACHS ASSET MANAGEMENT, L.P. (the "Company") does hereby make, constitute and appoint each of Abhishek V, Kateryna Osmachko, Ameen Soetan, Kshama Mishra, Papa Lette, Sunaina Kapoor, and Andrzej Szyszka (each, an "attorney-in-fact"), acting individually, its true and lawful attorney, to execute and deliver in its name and on its behalf whether the Company is acting individually or as representative of others, any and all filings required to be made by the Company under the Securities Exchange Act of 1934, (as amended, the "Act"), with respect to securities which may be deemed to be beneficially owned by the Company under the Act, giving and granting unto each said attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. THIS POWER OF ATTORNEY shall take effect on December 1st, 2023 and remain in full force and effect until the earlier of (i) December 1st, 2024 and (ii) such time that it is revoked in writing; provided that in the event an attorney-in-fact ceases to be an employee of the The Goldman Sachs Group, Inc. or one of its affiliates or ceases to perform the function in connection with which he/she was appointed attorney-in-fact prior to such time, this Power of Attorney shall cease to have effect in relation to any remaining attorneys-in- Fact upon such cessation but shall continue in full force and effect in relation to any remaining attornyes-in-fact. The Company has unrestriced right unilaterally to revoke this Power of Attorney. This Power of Attorney shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to rules of conflicts of law. IN WITNESS WHEREOF, the undersigned has duly subscribed these presents as of December 1, 2023. GOLDMAN SACHS ASSET MANAGEMENT, L.P. By: GSAM HOLDINGS LLC., its General Partner By: /s/ David Plutzer ____________________________ Name: David Plutzer Title: Authorized Signatory Page 8 of 8

Get the next $ZEPP alert in real time by email

SEC Form SC 13G/A filed by Zepp Health Corporation (Amendment)

2/8/24 5:22:46 PM ET

$ZEPP

Computer Manufacturing

Technology

Get the next $ZEPP alert in real time by email

SEC Form SC 13G/A filed by Zepp Health Corporation (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ZEPP

SEC Form SC 13G/A filed by Zepp Health Corporation (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ZEPP

$ZEPP
SEC Filings

Amendment: SEC Form SCHEDULE 13G/A filed by Zepp Health Corporation

SEC Form SCHEDULE 13G filed by Zepp Health Corporation

SEC Form 6-K filed by Zepp Health Corporation

$ZEPP
Press Releases

Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results

Zepp Health Corporation to Report Third Quarter 2025 Financial Results on November 4, 2025

Amazfit Expands HYROX Athlete Roster with Global Champions and Rising Stars

$ZEPP
Leadership Updates

NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador

Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador

Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador

$ZEPP
Financials

Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results

Zepp Health Corporation to Report Third Quarter 2025 Financial Results on November 4, 2025

Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages

$ZEPP
Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

SEC Form SC 13G/A filed by Zepp Health Corporation (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $ZEPP

SEC Form SC 13G/A filed by Zepp Health Corporation (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $ZEPP

$ZEPP SEC Filings

Amendment: SEC Form SCHEDULE 13G/A filed by Zepp Health Corporation

SEC Form SCHEDULE 13G filed by Zepp Health Corporation

SEC Form 6-K filed by Zepp Health Corporation

$ZEPP Press Releases

Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results

Zepp Health Corporation to Report Third Quarter 2025 Financial Results on November 4, 2025

Amazfit Expands HYROX Athlete Roster with Global Champions and Rising Stars

$ZEPP Leadership Updates

NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador

Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador

Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador

$ZEPP Financials

Zepp Health Corporation Reports Third Quarter 2025 Unaudited Financial Results

Zepp Health Corporation to Report Third Quarter 2025 Financial Results on November 4, 2025

Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages

$ZEPP Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

Amendment: SEC Form SC 13G/A filed by Zepp Health Corporation

Recent Analyst Ratings for
$ZEPP

Recent Analyst Ratings for
$ZEPP

$ZEPP
SEC Filings

$ZEPP
Press Releases

$ZEPP
Leadership Updates

$ZEPP
Financials

$ZEPP
Large Ownership Changes